This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Centre National De La Recherche Scientifique, Université Paris Descartes. Active years: 2014-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2014-2015
Title: David Ogden: Innovator in Organic Compounds
Introduction
David Ogden is a notable inventor based in Rambouillet, France. He has made significant contributions to the field of organic compounds, particularly in the development of multiphoton and photon activable derivatives. With a total of 2 patents, Ogden's work has implications in various scientific and pharmaceutical applications.
Latest Patents
Ogden's latest patents include "Multiphoton activable quinoline derivatives, their preparation and their uses." This invention focuses on organic compounds that can be activated by multiphoton processes. It also details a method for synthesizing these compounds and their specific applications in aqueous solutions. Another significant patent is "X-ray and gamma-photon activable organic compounds, their preparation and their uses." This invention describes compounds that respond to X-ray and gamma-photon activation, along with methods for their synthesis and use in pharmaceutical compositions.
Career Highlights
Throughout his career, David Ogden has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and Université Paris Descartes. His research has contributed to advancements in the understanding and application of organic compounds in various fields.
Collaborations
Ogden has collaborated with notable colleagues, including Peter Dalko and Morgane Petit. These partnerships have fostered innovation and development in his research endeavors.
Conclusion
David Ogden's contributions to the field of organic compounds through his patents and collaborations highlight his role as an influential inventor. His work continues to impact scientific research and pharmaceutical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile